Literature DB >> 23188703

X-ray repair cross-complementing group 1 Arg399Gln gene polymorphism and susceptibility to colorectal cancer:a meta-analysis.

Fu-Ren Zeng1, Yang Ling, Jie Yang, Xiao-Cai Tian, Xin Yang, Rong-Cheng Luo.   

Abstract

X-ray repair cross-complementing group 1 (XRCC1), a DNA repair enzyme, plays a crucial role in the base excision repair by generating a single nucleotide repair patch. It has been demonstrated that the XRCC1 Arg399Gln gene polymorphism was associated with variations in XRCC1 enzyme activity. The aim of this study was to quantitatively summarize the association between the XRCC1 Arg399Gln polymorphism and susceptibility to colorectal cancer (CRC). A comprehensive search of the PubMed, Embase, and China National Knowledge Infrastructure databases was conducted for studies on the association between the XRCC1 Arg399Gln polymorphism and CRC risk. Summary odds ratio (OR) with its corresponding 95 % confidence interval (95 %CI) was estimated, in a fixed-effects model or a random-effects model when appropriate, to assess the association. Totally, 26 case-control studies with 6,979 cases and 11,470 controls were included into this meta-analysis. The pooled results of total studies showed that the XRCC1 Arg399Gln polymorphism was significantly associated with increased risk of CRC in all genetic contrast models (OR(A vs. G) = 1.13, 95 %CI 1.03-1.23, P (OR) = 0.008; OR(Gln/Gln vs. Arg/Arg) = 1.24, 95 %CI 1.04-1.46, P (OR) = 0.015; OR(Gln/Gln vs. Arg/Gln + Arg/Arg) = 1.19, 95 %CI 1.03-1.38, P (OR) = 0.021; OR(Gln/Gln + Arg/Gln vs. Arg/Arg) = 1.14, 95 %CI 1.02-1.28, P (OR) = 0.022), except for the additive contrast model (OR(Arg/Gln vs. Arg/Arg) = 1.11, 95 %CI 0.99-1.25, P (OR) = 0.064). The statistically significant association between the XRCC1 Arg399Gln polymorphism and CRC risk was observed among studies with high quality and in Asians, but not in Caucasians. Sensitivity analyses by sequential omission of any individual studies further identified the significant association. Publication bias was inexistent in this meta-analysis. The meta-analysis suggests that the XRCC1 Arg399Gln polymorphism is associated with increased risk of CRC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23188703     DOI: 10.1007/s13277-012-0581-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  38 in total

1.  Investigation of nonspecific cross-reacting antigen 2 as a prognostic biomarker in bone marrow plasma from colorectal cancer patients.

Authors:  Kristina Schee; Kjersti Flatmark; Ruth Holm; Kjetil Boye; Elisabeth Paus
Journal:  Tumour Biol       Date:  2011-10-18

2.  The comparison of percentages in matched samples.

Authors:  W G COCHRAN
Journal:  Biometrika       Date:  1950-12       Impact factor: 2.445

3.  Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity.

Authors:  A E Stuck; L Z Rubenstein; D Wieland
Journal:  BMJ       Date:  1998-02-07

4.  No association of XRCC1 polymorphisms Arg194Trp and Arg399Gln with colorectal cancer risk.

Authors:  Andrea Gsur; Kathrin Bernhart; Andreas Baierl; Elisabeth Feik; Gerhard Führlinger; Philipp Hofer; Gernot Leeb; Karl Mach; Michael Micksche
Journal:  Cancer Epidemiol       Date:  2011-05-25       Impact factor: 2.984

5.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

6.  Association between polymorphisms of biotransformation and DNA-repair genes and risk of colorectal cancer in Taiwan.

Authors:  Chih-Ching Yeh; Fung-Chang Sung; Reiping Tang; Chung Rong Chang-Chieh; Ling-Ling Hsieh
Journal:  J Biomed Sci       Date:  2006-12-27       Impact factor: 8.410

7.  The C/A polymorphism in intron 11 of the XPC gene plays a crucial role in the modulation of an individual's susceptibility to sporadic colorectal cancer.

Authors:  Justyna Gil; Dave Ramsey; Agnieszka Stembalska; Pawel Karpinski; Karolina A Pesz; Izabela Laczmanska; Przemyslaw Leszczynski; Zygmunt Grzebieniak; Maria Malgorzata Sasiadek
Journal:  Mol Biol Rep       Date:  2011-05-11       Impact factor: 2.316

8.  Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma.

Authors:  Ming-Whei Yu; Shi-Yi Yang; I-Jen Pan; Chih-Lin Lin; Chun-Jen Liu; Yun-Fan Liaw; Shi-Ming Lin; Pei-Jer Chen; Shou-Dong Lee; Chien-Jen Chen
Journal:  J Natl Cancer Inst       Date:  2003-10-01       Impact factor: 13.506

9.  Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer.

Authors:  Karen Curtin; Wade S Samowitz; Roger K Wolff; Cornelia M Ulrich; Bette J Caan; John D Potter; Martha L Slattery
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

10.  Facial artery and atherosclerosis.

Authors:  A Md; W J; T A; C A; S R
Journal:  Folia Morphol (Warsz)       Date:  1999       Impact factor: 1.183

View more
  13 in total

1.  The APE1 Asp148Glu polymorphism and colorectal cancer susceptibility: a meta-analysis.

Authors:  Erdong Shen; Chuan Liu; Li Wei; Jianbing Hu; Jie Weng; Qinghua Yin; Yajie Wang
Journal:  Tumour Biol       Date:  2013-11-20

2.  APE1 polymorphisms are associated with colorectal cancer susceptibility in Chinese Hans.

Authors:  Shi-Heng Zhang; Lin-Ang Wang; Zheng Li; Yu Peng; Yan-Ping Cun; Nan Dai; Yi Cheng; He Xiao; Yan-Li Xiong; Dong Wang
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

3.  Polymorphisms in genes of APE1, PARP1, and XRCC1: risk and prognosis of colorectal cancer in a northeast Chinese population.

Authors:  Ye Li; Shuying Li; Zhiwei Wu; Fulan Hu; Lin Zhu; Xiaojuan Zhao; Binbin Cui; Xinshu Dong; Suli Tian; Fan Wang; Yashuang Zhao
Journal:  Med Oncol       Date:  2013-02-22       Impact factor: 3.064

Review 4.  XRCC1 R399Q polymorphism and colorectal cancer risk in the Chinese Han population: a meta-analysis.

Authors:  Chang-Jiang Qin; Kai-Wu Xu; Zhi-Hui Chen; Er-Tao Zhai; Yu-Long He; Xin-Ming Song
Journal:  Tumour Biol       Date:  2015-01-13

5.  Lack of association between interleukin-4 -524C>T polymorphism and colorectal cancer susceptibility.

Authors:  Huanlei Wu; Jia Hu; Bo Liu; Yu Tao; Xiao Zhou; Xianglin Yuan
Journal:  Tumour Biol       Date:  2013-12-07

Review 6.  Associations of CYP2E1 rs2031920 and rs3813867 polymorphisms with colorectal cancer risk: a systemic review and meta-analysis.

Authors:  Hui Peng; Shang-Kui Xie; Mei-Jin Huang; Dong-Lin Ren
Journal:  Tumour Biol       Date:  2013-04-18

7.  XRCC1 Arg194Trp polymorphism is associated with oral cancer risk: evidence from a meta-analysis.

Authors:  Yi Zhang; Yin Wang; Jian Wu; Long-Jiang Li
Journal:  Tumour Biol       Date:  2013-05-17

8.  XRCC1 codon 280 polymorphism and susceptibility to lung cancer: a meta-analysis of the literatures.

Authors:  Qin-xiang Guo; Wei-hua Yang; Jin-fang Zhai; Fu-cai Han; Chun-yan Wang
Journal:  Tumour Biol       Date:  2013-06-04

9.  SMAD7 rs12953717 polymorphism contributes to increased risk of colorectal cancer.

Authors:  Yanliang Hu; Zhifang Sun; Anhua Zhang; Jinjie Zhang
Journal:  Tumour Biol       Date:  2013-08-16

10.  CYP2E1 T7632A and 9-bp insertion polymorphisms and colorectal cancer risk: a meta-analysis based on 4,592 cases and 5,918 controls.

Authors:  Jun Qian; Zhangfa Song; Yinxiang Lv; Xuefeng Huang
Journal:  Tumour Biol       Date:  2013-05-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.